AL
EW icon

Airain Ltd’s Edwards Lifesciences EW Stock Holding History

Airain Ltd’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$375K Sell
9,513
-36,903
-80% -$1.35M 0.02% 613
2017
Q1 		$1.46M Buy
+46,416
New +$1.45M 0.07% 277
2016
Q3 		– Sell
-295,209
Closed -$9.81M – 663
2016
Q2 		$9.81M Buy
295,209
+269,700
+1,057% +$9.23M 0.57% 42
2016
Q1 		$750K Buy
+25,509
New +$704K 0.05% 356
2014
Q4 		– Sell
-21,546
Closed -$367K – 767
2014
Q3 		$367K Buy
+21,546
New +$340K 0.02% 527
2013
Q4 		– Sell
-135,150
Closed -$1.57M – 609
2013
Q3 		$1.57M Buy
+135,150
New +$1.58M 0.29% 91

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Airain Ltd's EW Position: Q2 2017 in Review

Airain Ltd reduced its Edwards Lifesciences (EW) stake by 80% in Q2 2017, selling an estimated $1.35M and leaving 9,513 shares worth $375K. The position accounts for 0.02% of the portfolio, ranked #613.

Airain Ltd first reported a position in EW in Q3 2013 and has held it in 6 quarters since. The position peaked at $9.81M in Q2 2016. 720 funds tracked by Wall St. Rank hold EW as of Q2 2017.

  • Airain Ltd held 9,513 shares of Edwards Lifesciences worth $375K as of Q2 2017.
  • Airain Ltd sold 36,903 Edwards Lifesciences shares in Q2 2017, an estimated $1.35M.
  • Edwards Lifesciences made up 0.02% of Airain Ltd's portfolio in Q2 2017, its #613 holding.
  • Airain Ltd first reported a position in Edwards Lifesciences in Q3 2013 and has held it in 6 quarters since.
  • Airain Ltd's Edwards Lifesciences position peaked at $9.81M in Q2 2016.
  • 720 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.